Monoclonal Antibodies Preventing the Development of Polyarthritis in Rats Induced by Experimental Infection with Erysipelas Bacteria

References

• Schulz L C, Drommer W, Seidler D, et al. Experimenteller Rotlauf bei verschiedenen Spezies als Modell einer sys-temischen Bindegewebskrankheit. I. Systemische vasku-låre Prozesse bei der Organmanifestation. Beitr Pathol 1975a; 154: 1–26
   PubMedGoogle Scholar
• Schulz L C, Drommer W, Seidler D, Ehard H, Leimbeck R, Weiss R. Experimenteller Rotlauf bei verschiedenen Spezies als Modell einer systemischen Bindegewebskrankheit. II. Chronische Phase unter besonderer Berücksichti-gung der Polyarthritis. Beitr Pathol 1975; 154: 27–51
   PubMedGoogle Scholar
• Schulz L C. Zwei-Phasenkonzept der rheumatoiden Ent-zündung. Pathomechanismen am Modell der Rotlauf-Polyarthritis der Ratte, F. Enke, Stuttgart 1980
   Google Scholar
• Schulz L C, Ehard H, Hermanns W, . The different phases of Erysipelothrix polyarthritis: Comparison with other microbial models. Arthritis, Models and Mechanisms, H Deicher, L C Schulz, et al. Springer, Berlin, Heidelberg, New York 1981; 12–23
   Google Scholar
• Hermanns W, Jessen H, Schulz L C, Kerlen G, Böhm K H. Über die Induktion einer chronischen Polyarthritis mit Bestandteilen von Rotlaufbakterien (Erysipelothrix rhusiopathiae). 2. Mitteilung: Versuche zur Arthritis-Induktion bei Ratten. Zentralbl Veterinarmed [B] 1982; 20: 85–98
   Google Scholar
• Denecke R, Trautwein G. Lokale Antigenpersistenz und Chronizität der experimentellen Rotlauf-Polyarthritis. Berl Munch Tierarztl Wochenschr 1986; 99: 200–8
   PubMedGoogle Scholar
• Hermanns W. Die Rotlaufpolyarthritis der Ratte. Enzym-und Immun histochemische Untersuchungen zur Erreger-Wirt-Interaktion. Habilitationsschrift, Veterinary school, Hannover 1986
   Google Scholar
• Trautwein G, Seidler G, Schulz L C, Drommer W, Weiß R BO, Uhm K H. Immunologic und Pathogenese der chronischen Rotlauf-Polyarthritis des Schweines. Z Rheumatol 1976; 35: 217–39
   PubMedGoogle Scholar
• Schulz L C, Schaening U, Pena M, Hermanns W. Borderline-tissues as sites of antigen deposition and persistence -a unifying concept of rheumatoid arthritis?. Rheumatol Int 1985; 5: 221–7
   PubMed Web of Science ®Google Scholar
• Renz H, Gentz U, Schmidt A, Dapper T, Nain M, Gemsa D. Activation of macrophages in an experimental rat model of arthritis induced by Erysipelothrix rhusiopathiae infection. Infect Immun 1989; 57: 3172–80
   PubMed Web of Science ®Google Scholar
• Hermanns W, Schulz L C. Persistenz des arthritogenen Erregers und entzündliche Reaktion bei der chronischen Rotlauf-Arthritis der Ratte. Patho-mechanismen entzündlicher rheumatischer Erkrankungen bei Mensch und Tier, H Deicher. VCH Publishers, Weinheim 1989; 177–87
   Google Scholar
• Bohm K H, Franke F, Bihr K H, Hazem A S, Schulze W. Versuche zur Erzeugung von chronischem Rotlauf beim Schwein. II. Lebendantigenversuche zur Standardisierung einer Modellkrankheit. Zentralbl Veterinarmed [B] 1975; 22: 556–95
   PubMedGoogle Scholar
• Bisping W, Böhm K H, Weiland E. Zur derzeitigen Ver-laufsform des chronischen Rotlaufs beim Schwein Teil III. Bakteriologische und serologische Ergebnisse. Dtsch Tie-rarztl Wochenschr 1968; 75: 445–50
   PubMedGoogle Scholar
• Wonigeit K, Hermanns W, Hedrich H J, Franz B. Genetic control of susceptibility to infection with Erysipelothrix rhusiopathiue in the rat. Effect of major histo compatibility complex (MHC) and non-MHC genes. Transplant Proc 1987; 19: 3215–7
   Google Scholar
• Galfre G, Howe S C, Milstein C, Butcher G W, Howard J C. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 1977; 266: 550–2
   PubMed Web of Science ®Google Scholar
• Bazin H. Rat hybridomas and rat monoclonal antibodies. CRC press, Boca Raton 1989
   Google Scholar
• Terashima M, Uezumi I, Tomio T, et al. A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide. Infect lmmun 1991; 59: 1–6
   PubMedGoogle Scholar
• Gigliotti F, Hughes W T. Passive immuno prophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest 1988; 81: 1666–8
   PubMed Web of Science ®Google Scholar
• Coughlin R T, Bogard W C, Jr. Immuno protective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia cofi O III:B4 Lipopolysaccharide (LPS). J Immunol 1987; 139: 55741
   Google Scholar
• Hadler N M, Granovetter D A. Phlogistic properties of bacterial debris. Semin Arthritis Rheum 1978; 8: 1–16
   PubMedGoogle Scholar
• Larsson P, Holmdahl R, Dencker L, Klareskog L. In vivo treatment with W3/13 (anti-pan-T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology 1985; 56: 383–91
   PubMed Web of Science ®Google Scholar
• Ranges G E, Sriram S, Cooper S M. Prevention of Type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 1985; 162: 1105–10
   PubMed Web of Science ®Google Scholar
• Billingham M EJ, Fairchild S, Griffin E, Drayer L, Hicks C. Monoclonal antibody therapy for arthritis. Therapeutic approaches to inflammatory diseases, A J Lewis, N S Doherty, N R Ackerman. Elsevier Science Publishing, Cambridge 1989; 242–53
   Google Scholar
• Yoshino S, Kinne R, Hunig T, Emmrich F. The suppres-sive effect of an antibody to the apcell receptor in rat adjuvant arthritis: studies on optimal treatment protocols. J Autoimmun 1990; 7: 255–66
   Google Scholar
• Seki N, Sudo Y, Yoshioka T, et al. Type II collagen-induced murine arthritis I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1988; 140: 1477–84
   Google Scholar
• Cohen I R, Cooke A. Natural auto antibodies might prevent autoimmune disease. Immunol today 1986; 7: 363–4
   PubMedGoogle Scholar
• Clough J D, Valenzuela R. Relationship of renal histo-pathology in SLE nephritis to immunoglobulin class of anti-DNA. Am J Med 1980; 68: 80–5
   PubMedGoogle Scholar
• Myers L K, Stuart J M, Seyer J M, Kang A H. Identification of animmuno suppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med 1989; 170: 1999–2010
   PubMed Web of Science ®Google Scholar
• Billingham M EJ, Carney S, Butler R, Colston M J. A mycobacterial 65–kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med 1990; 171: 339–44
   PubMed Web of Science ®Google Scholar